Circulating microparticles from obstructive sleep apnea syndrome patients induce endothelin-mediated angiogenesis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 2, 2014, Pages 202-207

  Tual Chalot, Simon ^a,b   Gagnadoux, Frédéric ^a,b,c   Trzepizur, Wojciech ^a,b,c   Priou, Pascaline ^a,b,c   Andriantsitohaina, Ramaroson ^a,b,d   Martinez, M Carmen ^a,b  

^a LUNAM Universite   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d NONE

Author keywords

Angiogenesis; Endothelin 1; Human endothelial cell; Microparticle; Obstructive sleep apnea syndrome

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE; VASCULOTROPIN;

ADULT; ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EPWORTH SLEEPINESS SCALE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; OXYGEN DESATURATION; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; WESTERN BLOTTING;

ANGIOGENESIS; ENDOTHELIN-1; HUMAN ENDOTHELIAL CELL; MICROPARTICLE; OBSTRUCTIVE SLEEP APNEA SYNDROME;

ADULT; AGED; AORTA; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; ENDOTHELIN-1; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES; PIPERIDINES; RECEPTOR, ENDOTHELIN B; SLEEP APNEA, OBSTRUCTIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84890182212     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.11.017     Document Type: Article

References (33)

1. Martinez M.C., Andriantsitohaina R. Microparticles in angiogenesis: therapeutic potential. Circ. Res. 2011, 109:110-119.
2. Priou P., Gagnadoux F., Tesse A., Mastronardi M.L., Agouni A., Meslier N., Racineux J.L., Martinez M.C., Trzepizur W., Andriantsitohana R. Endothelial dysfunction and circulating microparticles from patients with obstructive sleep apnea. Am. J. Pathol. 2010, 177:974-983.
3. Tual-Chalot S., Fatoumata K., Priou P., Trzepizur W., Gaceb A., Contreras C., Prieto D., Martinez M.C., Gagnadoux F., Andriantsitohaina R. Circulating microparticles from patients with obstructive sleep apneas enhance vascular contraction: mandatory role of the endothelium. Am. J. Pathol. 2012, 181:1473-1482.
4. Baguet J.P., Barone-Rochette G., Tamisier R., Levy P., Pépin J.L. Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat. Rev. Cardiol. 2012, 9:679-688.
5. Chatsuriyawong S., Gozal D., Kheirandish-Gozal L., Bhattacharjee R., Khalyfa A.A., Wang Y., Sukhumsirichart W., Khalyfa A. Polymorphisms in nitric oxide synthase and endothelin genes among children with obstructive sleep apnea. BMC Med. Genomics 2013, 6:29.
6. Gjørup P.H., Sadauskiene L., Wessels J., Nyvad O., Strunge B., Pedersen E.B. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am. J. Hypertens. 2007, 20:44-52.
7. Gjørup P.H., Wessels J., Pedersen E.B. Abnormally increased nitric oxide synthesis and increased endothelin-1 in plasma in patients with obstructive sleep apnoea. Scand. J. Clin. Lab. Invest. 2008, 68:375-385.
8. Phillips B.G., Narkiewicz K., Pesek C.A., Haynes W.G., Dyken M.E., Somers V.K. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J. Hypertens. 1999, 17:61-66.
9. Zamarrón C., Riveiro A., Gude F. Circulating levels of vascular endothelial markers in obstructive sleep apnoea syndrome. Effects of nasal continuous positive airway pressure. Arch. Med. Sci. 2011, 7:1023-1028.
10. Karkoulias K., Lykouras D., Sampsonas F., Drakatos P., Canova S., Tsoukalas G., Spiropoulos K. The role of Endothelin-1 in obstructive sleep apnea syndrome and pulmonary arterial hypertension: pathogenesis and Endothelin-1 antagonists. Curr. Med. Chem. 2010, 17:1059-1066.
11. Wang Z., Li A.Y., Guo Q.H., Zhang J.P., An Q., Guo Y.J., Chu L., Weiss J.W., Ji E.S. Effects of cyclic intermittent hypoxia on ET-1 responsiveness and endothelial dysfunction of pulmonary arteries in rats. PLoS One 2013, 8:e58078.
12. Webster B.R., Osmond J.M., Paredes D.A., DeLeon X.A., Jackson-Weaver O., Walker B.R., Kanagy N.L. Phosphoinositide-dependent kinase-1 and protein kinase Cδ contribute to endothelin-1 constriction and elevated blood pressure in intermittent hypoxia. J. Pharmacol. Exp. Ther. 2013, 344:68-76.
13. Belaidi E., Joyeux-Faure M., Ribuot C., Launois S.H., Levy P., Godin-Ribuot D. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J. Am. Coll. Cardiol. 2009, 53:1309-1317.
14. Almendros I., Montserrat J.M., Ramírez J., Torres M., Duran-Cantolla J., Navajas D., Farré R. Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea. Eur. Respir. J. 2012, 39:215-217.
15. Berger S., Lavie L. Endothelial progenitor cells in cardiovascular disease and hypoxia-potential implications to obstructive sleep apnea. Transl. Res. 2011, 158:1-13.
16. Steiner S., Schueller P.O., Schulze V., Strauber B.E. Occurrence of coronary collateral vessels in patients with sleep apnea and total coronary occlusion. Chest 2010, 137:516-520.
17. Schulz R., Hummel C., Heinemann S., Seeger W., Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am. J. Respir. Crit. Care Med. 2002, 165:67-70.
18. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
19. Pelletier-Fleury N., Meslier N., Gagnadoux F., Person C., Rakotonanahary D., Ouksel H., Fleury B., Racineux J.L. Economic arguments for the immediate management of moderate-to-severe obstructive sleep apnoea syndrome. Eur. Respir. J. 2004, 23:53-60.
20. Kushida C.A., Littner M.R., Morgenthaler T., Alessi C.A., Bailey D., Jr Coleman J., Friedman L., Hirshkowitz M., Kapen S., Kramer M., Lee-Chiong T., Loube D.L., Owens J., Pancer J.P., Wise M. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005, 28:499-521.
21. Mostefai H.A., Meziani F., Mastronardi M.L., Agouni A., Heymes C., Sargentini C., Asfar P., Martinez M.C., Andriantsitohaina R. Circulating microparticles from patients with septic shock exert protective role in vascular function. Am. J. Respir. Crit. Care Med. 2008, 178:1148-1155.
22. Agouni A., Lagrue-Lak-Hal A.H., Ducluzeau P.H., Mostefai H.A., Draunet-Busson C., Leftheriotis G., Heymes C., Martinez M.C., Andriantsitohaina R. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am. J. Pathol. 2008, 173:1210-1219.
23. Ohtsuka M., Sasaki K., Ueno T., Seki R., Nakayoshi T., Koiwaya H., Toyama Y., Yokoyama S., Mitsutake Y., Chibana H., Itaya N., Okamura T., Imaizumi T. Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients. Atherosclerosis 2013, 227:275-282.
24. Chahed S., Leroyer A.S., Benzerroug M., Gaucher D., Georgescu A., Picaud S., Silvestre J.S., Gaudric A., Tedgui A., Massin P., Boulanger C.M. Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation. Diabetes 2010, 59:694-701.
25. Tsimerman G., Roguin A., Bachar A., Melamed E., Brenner B., Aharon A. Involvement of microparticles in diabetic vascular complications. Thromb. Haemost. 2011, 106:310-321.
26. Gaustad J.V., Simonsen T.G., Roa A.M., Rofstad E.K. Tumors exposed to acute cyclic hypoxia show increased vessel density and delayed blood supply. Microvasc. Res. 2013, 85:10-15.
27. Rofstad E.K., Gaustad J.V., Egeland T.A., Mathiesen B., Galappathi K. Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination. Int. J. Cancer 2010, 127:1535-1546.
28. Tual-Chalot S., Guibert C., Muller B., Savineau J.P., Andriantsitohaina R., Martínez M.C. Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction. Am. J. Respir. Crit. Care Med. 2010, 182:261-268.
29. Rubin L.J. Endothelin receptor antagonists for the treatment of pulmonary artery hypertension. Life Sci. 2012, 91:517-521.
30. Salani D., Taraboletti G., Rosanò L., Di Castro V., Borsotti P., Giavazzi R., Bagnato A. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am. J. Pathol. 2000, 157:1703-1711.
31. Luo J., Martinez J., Yin X., Sanchez A., Tripathy D., Grammas P. Hypoxia induces angiogenic factors in brain microvascular endothelial cells. Microvasc. Res. 2012, 83:138-145.
32. Ye L., Pien G.W., Weaver T.E. Gender differences in the clinical manifestation of obstructive sleep apnea. Sleep Med. 2009, 10:1075-1084.
33. Mazzuca E., Battaglia S., Marrone O., Marotta A.M., Castrogiovanni A., Esquinas C., Barcelò A., Barbé F., Bonsignore M.R. Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea. J. Sleep Res. 2013, 10.1111/jsr.12088.